IL6 and keratitis: Furthermore, Rebibo et al. elaborated TAC-loaded nanocapsules enabling a superior anti-inflammatory effect on an anterior chamber LPS-induced murine model of keratitis in comparison to the drug in oil solution and with a significant decrease in macrophage inflammatory protein 2 and IL-6, among other evaluated inflammatory markers [32].